Bill

Bill > SB1495


TN SB1495

TN SB1495
AN ACT to amend Tennessee Code Annotated, Title 20 and Title 33, relative to opioids.


summary

Introduced
12/23/2025
In Committee
Crossed Over
02/19/2026
Passed
05/05/2026
Dead
Signed/Enacted/Adopted
05/18/2026

Introduced Session

114th General Assembly

Bill Summary

As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.

AI Summary

This bill amends Tennessee Code Annotated, specifically sections 20-13-203 and 33-11-103(p), to add Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to a list of companies that may be released by the state's attorney general from pending or future legal claims related to opioids, in addition to Purdue Pharma L.P. This action is part of ongoing efforts to address the opioid crisis and potentially resolve legal disputes with pharmaceutical companies involved in the production and distribution of opioid medications. The bill also includes a standard severability clause, meaning that if any part of the act is found to be invalid, the rest of the act will still remain in effect.

Committee Categories

Justice

Sponsors (1)

Last Action

Effective date(s) 05/05/2026 (on 05/18/2026)

Bill Topics

Health
  • ‐ Drug Abuse, Treatment, and Education
Law, Crime, and Family Issues
  • ‐ Civil Law and Procedure

bill text


bill summary

Loading...

bill summary

Loading...
Loading...